Home > Efficacious non-steroidal topical for psoriasis

Efficacious non-steroidal topical for psoriasis

Presented By
Prof. Mark Lebwohl, Icahn School of Medicine at Mount Sinai, USA
Conference
EADV 2020
Once-daily tapinarof 1% cream has shown highly significant treatment success in a substantial proportion of psoriasis patients in the identical, multicentre, phase 3 PSOARING 1 and PSOARING 2 trials. “In psoriasis, we have a significant need for effective topical therapies that do not restrict the amount of time we can apply them or the locations on the body where we can apply them,” stated Prof. Mark Lebwohl (Icahn School of Medicine at Mount Sinai, USA) [1]. He referred to restrictions of high-potent topical corticosteroids that cannot be used in the face or intertriginous sites, for example. Tapinarof is a first in class, non-steroidal topical aryl hydrocarbon receptor-modulating agent. “Tapinarof enters the cell where it binds to the aryl hydrocarbon receptor. That complex then enters the nucleus where it joins with the aryl hydrocarbon receptor nuclear translocator and that entire complex regulates gene expression, resulting in a reduction in i...


Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on